MA41997A - Combinaisons de cannabinoïdes et de n-acyléthanolamines - Google Patents
Combinaisons de cannabinoïdes et de n-acyléthanolaminesInfo
- Publication number
- MA41997A MA41997A MA041997A MA41997A MA41997A MA 41997 A MA41997 A MA 41997A MA 041997 A MA041997 A MA 041997A MA 41997 A MA41997 A MA 41997A MA 41997 A MA41997 A MA 41997A
- Authority
- MA
- Morocco
- Prior art keywords
- acylethanolamines
- cannabinoids
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562154144P | 2015-04-29 | 2015-04-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41997A true MA41997A (fr) | 2021-03-31 |
Family
ID=57199061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA041997A MA41997A (fr) | 2015-04-29 | 2016-04-19 | Combinaisons de cannabinoïdes et de n-acyléthanolamines |
Country Status (12)
| Country | Link |
|---|---|
| US (7) | US11234956B2 (fr) |
| EP (2) | EP3288553B1 (fr) |
| JP (2) | JP6938465B2 (fr) |
| CN (2) | CN107530317A (fr) |
| AU (4) | AU2016254685B2 (fr) |
| CA (1) | CA2984088C (fr) |
| DK (1) | DK3288553T3 (fr) |
| ES (1) | ES2935605T3 (fr) |
| IL (2) | IL291864A (fr) |
| MA (1) | MA41997A (fr) |
| PL (1) | PL3288553T3 (fr) |
| WO (1) | WO2016174661A1 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6938465B2 (ja) * | 2015-04-29 | 2021-09-22 | エスシーアイ スパーク リミティド | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
| WO2019136351A1 (fr) * | 2018-01-05 | 2019-07-11 | Altus Labs, Llc | Compositions de soins d'hygiène personnelle |
| US20220000833A1 (en) * | 2018-01-29 | 2022-01-06 | Therapix Biosciences Ltd. | Compositions and methods for treating obstructive sleep apnea |
| MX2020010424A (es) * | 2018-04-03 | 2021-01-15 | Pure Green Pharmaceuticals Inc | Comprimido o composicion que contiene n-acil etanolamina y cannabinoides. |
| WO2020160452A1 (fr) * | 2019-02-01 | 2020-08-06 | Tess Ventures, Inc. | Combinaison de serm, de sarm et de cannabinoïdes destinée à améliorer la sécurité et l'efficacité d'endocrinothérapies |
| WO2020214569A1 (fr) * | 2019-04-15 | 2020-10-22 | Metagenics, Inc. | Nouvelle formulation de chanvre et de pois et son utilisation |
| MX2021012892A (es) * | 2019-04-23 | 2021-11-17 | Scisparc Ltd | Composiciones y metodos para potenciar derivados de 4-aminofenoles. |
| EP3965789A4 (fr) * | 2019-05-07 | 2023-01-25 | Ojai Energetics PBC | Méthodes de détermination optimisée de dosage de cannabinoïde |
| EP3972573A4 (fr) | 2019-05-23 | 2023-07-12 | India Globalization Capital, Inc. | Compositions et procédés utilisant des cannabinoïdes pour traiter le bégaiement et les symptômes du syndrome de la tourette |
| EP4017486A4 (fr) * | 2019-08-19 | 2023-09-20 | Buzzelet Development And Technologies Ltd | Compositions pour le traitement d'un état caractérisé par une déficience en anandamide et leurs utilisations |
| EP3838346A1 (fr) * | 2019-12-20 | 2021-06-23 | Chemo Research SL | Capsules de gélatine molle contenant du palmitoyléthanolamide et de l'acide alpha-lipoïque |
| WO2021141959A1 (fr) | 2020-01-10 | 2021-07-15 | Pacira Pharmaceuticals, Inc. | Traitement de la douleur par administration de compositions anesthésiques liposomales à libération prolongée |
| WO2021141963A1 (fr) | 2020-01-10 | 2021-07-15 | Pacira Pharmaceuticals, Inc. | Traitement de la douleur par administration sous-arachnoïdienne de compositions anesthésiques liposomales à libération prolongée |
| US11273122B2 (en) | 2020-02-11 | 2022-03-15 | Therese Mainella | Combination of cannabis, derivatives thereof and additives in oral care compositions |
| EP4274573A4 (fr) | 2021-01-11 | 2024-12-11 | Pacira Pharmaceuticals, Inc. | Traitement de la douleur de la hanche avec des compositions anesthésiques liposomales à libération prolongée |
| WO2023278768A1 (fr) * | 2021-06-30 | 2023-01-05 | Demetrix, Inc. | Soulagement de sensations de démangeaison à l'aide de composés cannabinoïdes |
| WO2023039419A2 (fr) | 2021-09-08 | 2023-03-16 | Plantible Foods Inc. | Systèmes et procédés de mesure de la densité d'un tapis d'une biomasse aquatique |
| WO2023200906A1 (fr) | 2022-04-12 | 2023-10-19 | Shackelford Pharma Inc. | Traitement de troubles épileptiques |
| US11918565B1 (en) | 2022-11-03 | 2024-03-05 | Pacira Pharmaceuticals, Inc. | Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions |
| US12226610B2 (en) | 2022-11-03 | 2025-02-18 | Pacira Pharmaceuticals, Inc. | Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions |
| WO2024124354A1 (fr) * | 2022-12-16 | 2024-06-20 | Aima Inc. | Compositions et méthodes de traitement ou de prévention de la douleur ou d'autres troubles |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2330681C (fr) * | 1998-05-29 | 2008-08-26 | Andrea Giuffrida | Elimination de la douleur au moyen de cannabinoides endogenes |
| US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
| GB2394894B (en) * | 2002-11-04 | 2005-08-31 | G W Pharma Ltd | New use for pharmaceutical composition |
| US20090054526A1 (en) | 2005-07-14 | 2009-02-26 | Hansen Harald S | Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| GB2432312A (en) * | 2005-11-01 | 2007-05-23 | Gw Pharma Ltd | Pharmaceutical compositions for the treatment of pain |
| ES2548190T3 (es) * | 2009-09-07 | 2015-10-14 | Epitech Group S.P.A. | Composición que contiene palmitoiletanolamida ultramicronizada |
| AT509000B1 (de) * | 2009-10-23 | 2012-12-15 | Rausch Peter | Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen |
| GB2495118B (en) * | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| EP2719375A1 (fr) * | 2012-10-10 | 2014-04-16 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Cannabinoïdes pour le traitement de cancers liés au mécanisme hedgehog |
| JP6938465B2 (ja) * | 2015-04-29 | 2021-09-22 | エスシーアイ スパーク リミティド | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
-
2016
- 2016-04-19 JP JP2018507796A patent/JP6938465B2/ja active Active
- 2016-04-19 EP EP16786064.2A patent/EP3288553B1/fr active Active
- 2016-04-19 ES ES16786064T patent/ES2935605T3/es active Active
- 2016-04-19 IL IL291864A patent/IL291864A/en unknown
- 2016-04-19 PL PL16786064.2T patent/PL3288553T3/pl unknown
- 2016-04-19 CN CN201680024534.5A patent/CN107530317A/zh active Pending
- 2016-04-19 AU AU2016254685A patent/AU2016254685B2/en active Active
- 2016-04-19 CN CN202310678191.6A patent/CN116549437A/zh active Pending
- 2016-04-19 WO PCT/IL2016/050414 patent/WO2016174661A1/fr not_active Ceased
- 2016-04-19 DK DK16786064.2T patent/DK3288553T3/da active
- 2016-04-19 EP EP22215663.0A patent/EP4193993A3/fr active Pending
- 2016-04-19 MA MA041997A patent/MA41997A/fr unknown
- 2016-04-19 US US15/570,118 patent/US11234956B2/en active Active
- 2016-04-19 CA CA2984088A patent/CA2984088C/fr active Active
-
2017
- 2017-10-24 IL IL255238A patent/IL255238B/en unknown
-
2019
- 2019-08-30 US US16/557,379 patent/US11207290B2/en active Active - Reinstated
- 2019-10-01 US US16/589,611 patent/US20200030281A1/en not_active Abandoned
- 2019-10-10 US US16/598,029 patent/US11197845B2/en active Active - Reinstated
-
2021
- 2021-03-30 JP JP2021057991A patent/JP2021107401A/ja active Pending
- 2021-07-19 AU AU2021206784A patent/AU2021206784B2/en active Active
- 2021-08-27 US US17/459,583 patent/US20210393577A1/en active Pending
- 2021-11-12 US US17/524,942 patent/US20220071948A1/en not_active Abandoned
- 2021-11-12 US US17/525,046 patent/US20220071949A1/en active Pending
-
2023
- 2023-10-17 AU AU2023251426A patent/AU2023251426B2/en active Active
-
2025
- 2025-12-31 AU AU2025287414A patent/AU2025287414A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL293377B1 (en) | Hsd17b13 variants and uses thereof | |
| IL255238B (en) | Combinations of cannabinoids and n-acylethanolamines | |
| IL282048A (en) | Oxysterols and methods of use thereof | |
| HUE052373T2 (hu) | Szubsztituált krománok és alkalmazási eljárások | |
| IL251972B (en) | Analyzing and utilizing landscapes | |
| IL251988A0 (en) | Glycan-interacting compounds and methods of use | |
| PT3548033T (pt) | Compostos e respectivos métodos de utilização | |
| IL247262B (en) | Cannabinoid compositions and uses | |
| EP4212536C0 (fr) | Composés de benzoxazepine oxazolidinone et procédés d'utilisation | |
| PT3295951T (pt) | Anticorpos anti-pvrig e métodos de utilização | |
| EP3344400A4 (fr) | Bio-imprimante de microtissu en trois dimensions | |
| DK3331876T3 (da) | Modulators of ror-gamma | |
| PL3265448T3 (pl) | Proleki riluzolu i ich zastosowanie | |
| BR112018000129A2 (pt) | oxiesteróis e seus métodos de utilização | |
| MA40933A (fr) | Difluorométhyl-aminopyridines et difluorométhyl-aminopyrimidines | |
| DK3132009T3 (da) | Fremgangsmåde | |
| DK3283210T3 (da) | Fremgangsmåde | |
| IL251836A0 (en) | Compositions and methods for physiological delivery using cannabidiol | |
| IL272200A (en) | Isochroman compounds and uses thereof | |
| BR112016025413A2 (pt) | método de fabricação de um inserto e inserto | |
| PL3393468T3 (pl) | Metody leczenia niedoboru odporności | |
| PT3337506T (pt) | Combinações e suas utilizações | |
| EP3398262A4 (fr) | Caractérisation et sélection de micro-routes | |
| IL254825A0 (en) | Methods of treatment with taselisib | |
| IL254502B (en) | Solid forms of menaquinols |